Gilead Sciences, Inc.

Gilead Sciences, Inc. is a research-based biopharmaceutical company headquartered in Foster City, California, dedicated to discovering and commercializing innovative medicines for life-threatening diseases. Since its founding in 1987, the firm has established itself as a global leader in antiviral therapies, particularly for HIV/AIDS, hepatitis B, hepatitis C, and COVID-19. Beyond its core expertise in virology, the company has expanded its focus into oncology, cell therapy, and inflammatory diseases to address significant unmet medical needs. Operating across six continents with a workforce of over 17,000 employees, Gilead remains committed to advancing transformative science and improving health equity for patients and communities worldwide.